Literature DB >> 3485575

Release of interleukin-1 by peripheral blood mononuclear cells in patients with tuberculosis and active inflammation.

S W Chensue, M P Davey, D G Remick, S L Kunkel.   

Abstract

Peripheral blood monocytes from patients with active tuberculosis and acute inflammatory disease showed spontaneous interleukin-1 production when compared with those from control patients or healthy controls. Moreover, interleukin-1 production appeared to be a more specific indicator of active disease than were other commonly used indices, such as the erythrocyte sedimentation rate and serum C-reactive protein levels.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3485575      PMCID： PMC262243          DOI： 10.1128/iai.52.1.341-343.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  10 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Automated quantitation of proteins in serum and other biologic fluids.

Authors:  R F Ritchie; C A Alper; J Graves; N Pearson; C Larson
Journal:  Am J Clin Pathol       Date:  1973-02       Impact factor: 2.493

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen.

Authors:  M B Sztein; S N Vogel; J D Sipe; P A Murphy; S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

5.  A comparison of the erythrocyte sedimentation rate and serum C-reactive protein concentration in elderly patients.

Authors:  R A Kenny; A P Saunders; A Coll; M G Harrington; D Caspi; H M Hodkinson; M B Pepys
Journal:  Age Ageing       Date:  1985-01       Impact factor: 10.668

6.  Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1984-04

7.  Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.

Authors:  J Alcocer-Varela; E Martinez-Cordero; D Alarcon-Segovia
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

8.  Correlation of disease activity in systemic vasculitis with serum C-reactive protein measurement. A prospective study of thirty-eight patients.

Authors:  C R Hind; C G Winearls; M B Pepys
Journal:  Eur J Clin Invest       Date:  1985-04       Impact factor: 4.686

9.  Interleukin 1 production by peripheral blood mononuclear cells from leprosy patients.

Authors:  S Watson; W Bullock; K Nelson; V Schauf; R Gelber; R Jacobson
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

Review 10.  Molecular basis of fever in humans.

Authors:  C A Dinarello; S M Wolff
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965
  10 in total
  11 in total

1.  Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases.

Authors:  J C Chang; A Wysocki; K M Tchou-Wong; N Moskowitz; Y Zhang; W N Rom
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

2.  In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients.

Authors:  J Cadranel; C Philippe; J Perez; B Milleron; G Akoun; R Ardaillou; L Baud
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Serum levels of C-reactive protein in patients with pulmonary tuberculosis and malignant tumors of the chest.

Authors:  P Maasilta; A A Kostiala
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

4.  Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs.

Authors:  Y Zhang; W N Rom
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

5.  Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.

Authors:  Y Zhang; M Doerfler; T C Lee; B Guillemin; W N Rom
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Serial study of C-reactive protein during fungal esophagitis and enterocolitis.

Authors:  I Kostiala; A A Kostiala; E Elonen
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

7.  Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat.

Authors:  Y Zhang; K Nakata; M Weiden; W N Rom
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

8.  Structural determination and Toll-like receptor 2-dependent proinflammatory activity of dimycolyl-diarabino-glycerol from Mycobacterium marinum.

Authors:  Elisabeth Elass-Rochard; Yoann Rombouts; Bernadette Coddeville; Emmanuel Maes; Renaud Blervaque; David Hot; Laurent Kremer; Yann Guérardel
Journal:  J Biol Chem       Date:  2012-07-13       Impact factor: 5.157

9.  Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components.

Authors:  Y Zhang; M Broser; H Cohen; M Bodkin; K Law; J Reibman; W N Rom
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Allele-specific induction of IL-1β expression by C/EBPβ and PU.1 contributes to increased tuberculosis susceptibility.

Authors:  Guoliang Zhang; Boping Zhou; Shaoyuan Li; Jun Yue; Hui Yang; Yuxin Wen; Senlin Zhan; Wenfei Wang; Mingfeng Liao; Mingxia Zhang; Gucheng Zeng; Carl G Feng; Christopher M Sassetti; Xinchun Chen
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.